Results 201 to 210 of about 742,802 (244)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2002
Viral hepatitis affects millions of people worldwide, making it one of the most important diseases in the field of hepatology. The response to the hepatitis A vaccine is optimal when targeted to patients with chronic hepatitis before development of hepatic decompensation.
Ricardo, Marrero, Eugene, Schiff
+10 more sources
Viral hepatitis affects millions of people worldwide, making it one of the most important diseases in the field of hepatology. The response to the hepatitis A vaccine is optimal when targeted to patients with chronic hepatitis before development of hepatic decompensation.
Ricardo, Marrero, Eugene, Schiff
+10 more sources
Current Opinion in Gastroenterology, 1999
Viral hepatitis is still one of the most common causes of acute and chronic liver disease worldwide. Major advances have been made in our knowledge of these diseases, many during the past year. Molecular biology and clinical studies have improved our understanding of the mechanisms of antiviral drugs, as well as viral resistance to therapy.
A, Regev, E R, Schiff
+7 more sources
Viral hepatitis is still one of the most common causes of acute and chronic liver disease worldwide. Major advances have been made in our knowledge of these diseases, many during the past year. Molecular biology and clinical studies have improved our understanding of the mechanisms of antiviral drugs, as well as viral resistance to therapy.
A, Regev, E R, Schiff
+7 more sources
The Nurse Practitioner, 1984
Many nurse practitioners are involved in providing care to patients who believe they have either been exposed to or contracted hepatitis. Discoveries and new developments in the field of viral hepatitis have made the diagnosis of hepatitis A and hepatitis B more definitive.
B, Dong, E C, Barton, B A, Mancini
openaire +2 more sources
Many nurse practitioners are involved in providing care to patients who believe they have either been exposed to or contracted hepatitis. Discoveries and new developments in the field of viral hepatitis have made the diagnosis of hepatitis A and hepatitis B more definitive.
B, Dong, E C, Barton, B A, Mancini
openaire +2 more sources
Current Opinion in Gastroenterology, 1986
Developments over the last four years in our understanding of viral hepatitis are analyzed. The molecular structure of hepatitis A has been established, and vaccines for prevention are under development. The recognition of the replicative and integrated stages of hepatitis B infection has allowed more rational approaches to therapy.
openaire +3 more sources
Developments over the last four years in our understanding of viral hepatitis are analyzed. The molecular structure of hepatitis A has been established, and vaccines for prevention are under development. The recognition of the replicative and integrated stages of hepatitis B infection has allowed more rational approaches to therapy.
openaire +3 more sources
Current Opinion in Gastroenterology, 2001
Viral hepatitis constitutes the most common entity seen in hepatology practice. Hepatitis A vaccination is recommended for patients with chronic hepatitis. Both lamivudine and interferon are established therapies against chronic hepatitis B, with other treatments not equally effective.
R, Amaro, E R, Schiff
openaire +2 more sources
Viral hepatitis constitutes the most common entity seen in hepatology practice. Hepatitis A vaccination is recommended for patients with chronic hepatitis. Both lamivudine and interferon are established therapies against chronic hepatitis B, with other treatments not equally effective.
R, Amaro, E R, Schiff
openaire +2 more sources
Current Opinion in Gastroenterology, 2000
Viral hepatitis accounts for most liver diseases seen in hepatology practice. In the past year studies have been focused on uncovering the basic mechanisms of viral-cellular interactions, the knowledge of which will contribute to more effective treatment. Hepatitis A virus outbreaks still occur, even in the most developed countries, which points to the
D, Mallat, E, Schiff
openaire +2 more sources
Viral hepatitis accounts for most liver diseases seen in hepatology practice. In the past year studies have been focused on uncovering the basic mechanisms of viral-cellular interactions, the knowledge of which will contribute to more effective treatment. Hepatitis A virus outbreaks still occur, even in the most developed countries, which points to the
D, Mallat, E, Schiff
openaire +2 more sources
Viral hepatitis and haemophilia
British Medical Bulletin, 1990Modern therapy with clotting factor concentrates has been dramatically successful in preventing and alleviating the worst effects of haemophilia. Before the mid to late 1980s, when effective methods of concentrate sterilization were introduced, such therapy was associated with a virtual certainty of transmission of viral hepatitis.
C A, Lee, P B, Kernoff
openaire +2 more sources
Seminars in Liver Disease, 1998
Viral hepatitis is a diffuse inflammatory reaction of the liver caused by hepatotropic viruses. Pathomorphologic studies have shown acidophilic bodies and hepatocyte dropout, features that are compatible with apoptosis. Using in situ terminal transferase labeling, the number of hepatocytes showing features of apoptosis in patients with chronic ...
J Y, Lau, X, Xie, M M, Lai, P C, Wu
openaire +2 more sources
Viral hepatitis is a diffuse inflammatory reaction of the liver caused by hepatotropic viruses. Pathomorphologic studies have shown acidophilic bodies and hepatocyte dropout, features that are compatible with apoptosis. Using in situ terminal transferase labeling, the number of hepatocytes showing features of apoptosis in patients with chronic ...
J Y, Lau, X, Xie, M M, Lai, P C, Wu
openaire +2 more sources
Postgraduate Medicine, 1967
As Australia antigen is related to the hepatitis virus that causes type B hepatitis, it is currently proposed that the antigen be called hepatitis B antigen (HBAg). About 5 percent of patients with acute HBAg-positive hepatitis become carriers of HBAg. When cirrhosis develops following acute viral hepatitis, in most instances it appears to evolve from ...
A G, Redeker, H S, Yamahiro
openaire +2 more sources
As Australia antigen is related to the hepatitis virus that causes type B hepatitis, it is currently proposed that the antigen be called hepatitis B antigen (HBAg). About 5 percent of patients with acute HBAg-positive hepatitis become carriers of HBAg. When cirrhosis develops following acute viral hepatitis, in most instances it appears to evolve from ...
A G, Redeker, H S, Yamahiro
openaire +2 more sources
Viral Hepatitis in the Elderly
American Journal of Gastroenterology, 2012As life expectancy continues to rise, elderly adults represent a rapidly growing proportion of the population. The likelihood of complications of acute and chronic liver disease and overall mortality are higher in elderly populations. Several physiological changes associated with aging, greater prevalence of co-morbid conditions, and cumulative ...
Andres F, Carrion, Paul, Martin
openaire +2 more sources